Production of Remdesivir to be ramped up: Govt

According to the national treatment protocol, remdesivir is one of the investigational drugs approved for use in treating hospitalised Covid-19 patients. With the rising cases, the demand for the drug has also shot up.
Union minister of state for chemicals and fertilizer Mansukh Mandaviya reviewed the availability of the drug in the country with all existing manufacturers at several meetings held on Monday and Tuesday(AFP)
Union minister of state for chemicals and fertilizer Mansukh Mandaviya reviewed the availability of the drug in the country with all existing manufacturers at several meetings held on Monday and Tuesday(AFP)
Updated on Apr 15, 2021 04:15 AM IST
Copy Link
By HT Correspondent, New Delhi

The Centre on Wednesday approved ramping up the production of antiviral drug remdesivir amid a sudden surge in Covid-19 cases across the country.

According to the national treatment protocol, remdesivir is one of the investigational drugs approved for use in treating hospitalised Covid-19 patients. With the rising cases, the demand for the drug has also shot up.

“The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month,” said Union ministry of chemicals and fertilisers in a statement issued on Wednesday.

Union minister of state for chemicals and fertilizer Mansukh Mandaviya reviewed the availability of the drug in the country with all existing manufacturers at several meetings held on Monday and Tuesday

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
OPEN APP
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Saturday, October 16, 2021